(Q82661563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

C-myc as a predictive marker for chemotherapy in metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

metastatic breast cancer

1 reference

inferred from title

author

Natasa Todorović-Raković

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Zora Nešković-Konstantinović

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dragica Nikolić-Vukosavljević

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

24 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Medicine

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

217-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22113465%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10238-011-0169-y

17 January 2020

exact match

0 references

cites work

Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes

1 reference

12 December 2020

Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis

1 reference

12 December 2020

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.

1 reference

12 December 2020

Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer

1 reference

12 December 2020

Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas

1 reference

12 December 2020

Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations

1 reference

12 December 2020

Proto-oncogene amplification and human breast tumor phenotype

1 reference

12 December 2020

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

1 reference

12 December 2020

Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant

1 reference

12 December 2020

Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay

1 reference

12 December 2020

Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer

1 reference

12 December 2020

Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer

1 reference

12 December 2020

Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array

1 reference

12 December 2020

Metastatic breast cancer survival according to HER2 and Topo2a gene status.

1 reference

12 December 2020

The MYC oncogene as a cancer drug target

1 reference

12 December 2020

Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells

1 reference

12 December 2020

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

1 reference

12 December 2020

Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo

1 reference

12 December 2020

c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells

1 reference

12 December 2020

Prognostic factors in human primary breast cancer: comparison of c-myc and HER2/neu amplification

1 reference

12 December 2020

Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor

1 reference

12 December 2020

c-Myc target genes involved in cell growth, apoptosis, and metabolism

1 reference

12 December 2020

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

1 reference

12 December 2020

High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers

1 reference

12 December 2020

MYC amplification in breast cancer: a chromogenic in situ hybridisation study

1 reference

12 December 2020

Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer

1 reference

12 December 2020

c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse

1 reference

12 December 2020

Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival

1 reference

12 December 2020

The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer

1 reference

12 December 2020

Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance

1 reference

12 December 2020

MYC regulation of a "poor-prognosis" metastatic cancer cell state

1 reference

12 December 2020

Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours

1 reference

12 December 2020

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer

1 reference

12 December 2020

In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast Tumors

1 reference

12 December 2020

Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification

1 reference

12 December 2020

Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer

1 reference

12 December 2020

Novel c-MYC target genes mediate differential effects on cell proliferation and migration

1 reference

12 December 2020

c-Myc in breast cancer

1 reference

12 December 2020

Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis

1 reference

12 December 2020

Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization

1 reference

12 December 2020

Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells

1 reference

12 December 2020

Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations

1 reference

12 December 2020

Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas

1 reference

12 December 2020

c-myc amplifications in primary breast carcinomas and their local recurrences.

1 reference

12 December 2020

Targeted therapies for the treatment of breast cancer in the post-trastuzumab era.

1 reference

12 December 2020

Contributions of Myc to tumorigenesis

1 reference

12 December 2020

Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial

1 reference

12 December 2020